Levorphanol and Fentanyl: Interaction Details

Brand names
Fentanyl
AbstralActiqFentora +3 more
Levorphanol
Levo-DromoranXyvona
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Fentanyl

Brand names
  • Abstral
  • Actiq
  • Fentora
  • Onsolis
  • Subsys
  • Ionsys

Levorphanol

Brand names
  • Levo-Dromoran
  • Xyvona

What Happens When You Take Levorphanol With Fentanyl

What can happen when they are taken together (rated Major)

Increased risk of respiratory and and an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using fentaNYL together with a depressant can raise the risk of serotonin syndrome, profound , , , coma, and death. The combination should be kept for patients in whom alternative treatments are inadequate.

When the combination cannot be avoided, the lowest effective dosages and the shortest possible duration of co-use should be prescribed, with dosages titrated according to clinical response. Patients should be watched for sedation, respiratory depression, and signs and symptoms of serotonin syndrome, and fentaNYL should be stopped if serotonin syndrome is suspected.123

For postoperative analgesia, treatment should begin with a lower dose of fentaNYL injection, and patients should be observed for signs of respiratory depression, sedation, and hypotension. Fluids and other measures for managing potential hypotension should be on hand.1

The Levorphanol and Fentanyl Interaction, Explained

Taking fentanyl and levorphanol together can be risky. Both are strong pain medicines, and each slows your breathing and makes you sleepy. Together, those effects add up and can cause extreme drowsiness, dangerously slow or shallow breathing, low blood pressure, and in the worst cases coma or death. Both drugs can also raise , so there is a higher chance of (agitation, sweating, shaking, fast heartbeat, fever, muscle stiffness).

This combination is usually saved for when other options aren't enough. If you need both, your care team can use the lowest effective doses for the shortest time and watch you closely. Don't change anything on your own. Talk with your pharmacist or doctor, and get urgent help if you notice trouble breathing or serotonin syndrome symptoms.

/ and additive activity with fentanyl and levorphanol (both full mu-opioid ). This is a interaction, not a -mediated one. Evidence: established. Severity: major. Onset: unspecified.

  • Risks: profound , respiratory depression, , coma, death, and .
  • Management: reserve combined use for patients with inadequate alternatives; use the lowest effective doses and shortest duration, titrating to clinical response.
  • Monitor: sedation, respiratory rate, blood pressure, and signs of toxicity.
  • Discontinue fentanyl if serotonin syndrome is suspected.
  • Postoperative: start with a lower fentanyl injection dose, and have fluids and other measures ready for hypotension.

See the 8 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Levorphanol and Fentanyl Interact

The likely mechanism

; additive

In short: Levorphanol and fentanyl both raise serotonin activity and slow brain activity, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Levorphanol and Fentanyl Interaction

Your care team can manage this combination, but it needs careful oversight.

  • They usually reserve the combination for when other options aren't adequate.
  • If both are needed, doses are kept as low as works and used for as short a time as possible. Doses may need to be adjusted and individualized by your care team based on how you respond.
  • Your team may monitor you more closely for sleepiness, slowed breathing, low blood pressure, and signs.
  • If serotonin syndrome is suspected, fentanyl is typically stopped by your clinicians.

Keep taking your medicines as prescribed, and tell your pharmacist or prescriber about all your medicines. Seek urgent help for trouble breathing, extreme drowsiness, confusion, fever, or muscle rigidity.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Levorphanol or Fentanyl need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

6 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection

    Observational studies have shown that using analgesics together with raises the risk of drug-related death compared with opioid analgesics used alone. Since other depressant drugs have similar pharmacological properties, a comparable risk can reasonably be expected when they are combined with opioid analgesics.123

  2. Report 2 · Study title

    Case scenario: opioid association with serotonin syndrome: implications to the practitioners

    A case report describes associated in a 58-year-old man with a history of chronic back pain who had been stable on treatment for pain and depression. His regimen consisted of transdermal fentaNYL 75 mcg/hr patches, oxyCODONE 5 mg/acetaminophen 325 mg twice daily, celecoxib 200 mg twice daily, citalopram 40 mg once daily, and mirtazapine 50 mg at night.

    He also took doxazosin 4 mg daily and zolpidem 12.5 mg as needed for insomnia. Because he reported inadequate pain control, the fentaNYL regimen was changed so that the patch was replaced every 2 days instead of every 3 days.

    About 1 week after this fentaNYL increase, he reported anxiety, tremulousness, fever, and sweating. CloNIDine 0.2 mg every 4 hours was started without any improvement.

    Symptoms persisted, and the next day he was given haloperidol and LORazepam for anxiety and agitation. He stopped his fentaNYL patch and, 2 days later, presented to the emergency room with opiate withdrawal.

    He was then diagnosed with serotonin syndrome even though the fentaNYL patch had been discontinued for 30 hours. Haloperidol, fentaNYL, oxyCODONE/acetaminophen, citalopram, and mirtazapine were stopped immediately, and symptoms resolved completely by the next day. Morphine sulfate was prescribed in place of fentaNYL, and citalopram and mirtazapine were restarted, with no recurrence of serotoninergic symptoms at follow-up.4

  3. Report 3 · Study title

    Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy

    associated with fentaNYL use during an esophagogastroduodenoscopy was reported in a 39-year-old woman who was also taking sertraline 100 mg daily as an outpatient. She first presented with hematemesis and had a history of alcoholic cirrhosis.

    Before the esophagogastroduodenoscopy, an octreotide and pantoprazole drip was begun, and she received 2 doses of fentaNYL 50 micrograms and 2 doses of midazolam 1 mg. After the procedure she became somnolent and extremely rigid in all four extremities, and vecuronium and etomidate were given for immediate intubation.

    The rigidity progressed, with diffuse diaphoresis, horizontal roving eye movements, and a fever of 105 degrees F. Because of the possibility of seizure activity, LORazepam 2 mg IV was given without improvement, and a propofol drip was started for continued during intubation.

    A CPK of 2800 units/L and an ammonia level of 340 micromols/L indicated . A CT scan of the brain ruled out an acute intracranial process, and the neurology team diagnosed serotonin syndrome due to an interaction between fentaNYL and sertraline.

    Propofol was continued for sedation, and she received supportive treatment with a cooling blanket and cyproheptadine. After 3 days her temperature and CPK normalized, and she was later extubated without further complications.5

  4. Report 4 · Study title

    Serotonin syndrome precipitated by fentanyl during procedural sedation

    after IV fentaNYL administration during surgical procedures was reported in 2 patients who were also taking (sertraline and escitalopram). The first patient received IV fentaNYL (50 mcg), midazolam (2 mg), and 2 doses of propofol (60 mg and 40 mg) at an outpatient surgery center before a carpal tunnel release.

    After surgery she began shivering and became increasingly agitated, and she was transferred to the emergency department. On presentation she was combative, diaphoretic, and confused, could not follow commands, and had , hypertension, hyperreflexia, and ankle clonus.

    Creatinine kinase rose to 613 units/L on hospital day 2. The toxicology service treated her with escalating doses of without improvement.

    She was then intubated and sedated with a continuous propofol infusion. She was extubated after 2 days, all symptoms had resolved by day 3, and she was discharged home.

    The second patient, a 59-year-old woman, was admitted for an omentectomy and received IV fentaNYL 250 micrograms, etomidate, vecuronium, morphine, and cephazolin. After extubation she became hypoxic and acidotic and was reintubated and moved to the ICU.

    On postoperative day 1 she was extubated, and she later became tachycardic and unable to follow commands. Examination showed agitation, diaphoresis, patellar hyperreflexia, and bilateral ankle clonus of 3 to 4 beats.

    Laboratory evaluation was notable for a peak creatine kinase of 1161 units/L on postoperative day 2. She was treated with LORazepam and cyproheptadine, and symptoms resolved after 3 days.6

  5. Report 5 · Study title

    Serotonin toxicity caused by an interaction between fentanyl and paroxetine

    A case of postoperative after fentaNYL given for general anesthesia and postoperative analgesia was reported in a 60-year-old woman who was also receiving PARoxetine. Her outpatient medications were limited to PARoxetine and thyroxine, for depression and hypothyroidism respectively.

    She was admitted for extensive resection of a recurrent left chest wall myxofibrosarcoma and received propofol and 200 mcg of fentaNYL to induce anesthesia. She also received a further 800 mcg of fentaNYL intraoperatively (intermittent 50 mcg boluses) and then a fentaNYL infusion (100 to 200 mcg/hr) for postoperative and analgesia (2545 mcg of fentaNYL over 36 hours).

    The infusion was continued for 36 hours after surgery, at which point neurological examination showed intermittent agitation, bilateral hypertonia and hyperreflexia, and bilateral inducible ankle clonus. Symptoms were more severe in the lower limbs and on the right side of the body.

    A CT scan of the brain was unremarkable, and all other findings, including thyroid function testing, were within normal limits except for elevated blood pressure (180/90 mmHg), which resolved spontaneously 24 hours after the procedure. fentaNYL was stopped, and 24 hours later neurological symptoms had improved markedly, with complete recovery by postoperative day 4. She was ultimately discharged home without further complications.7

  6. Report 6 · Study title

    Serotonin syndrome caused by interaction between citalopram and fentanyl

    A 65-year-old woman treated with citalopram for depression developed after a fentaNYL patch was started. She had recently been diagnosed with myelodysplastic/myeloproliferative disease, and her regular medications included RABEprazole, tolterodine, HYDROcodone, and over-the-counter .

    She was hospitalized with abdominal pain and worsening back pain, and a spontaneous retroperitoneal was found. During hospitalization, the worsening back pain was treated with a fentaNYL transdermal patch (25 mcg/hr).

    Within 24 hours of starting fentaNYL, she progressively developed increasing confusion, agitation, combativeness, upper extremity tremors, myoclonic jerks, hyperreflexia, and unsteady gait, consistent with serotonin syndrome. (110 to 120 beats per minute) was also observed.

    A CT scan and laboratory values showed no abnormalities. fentaNYL was discontinued, and all symptoms resolved within 24 to 36 hours. Symptoms did not recur when oxyCODONE was started for the back pain. Based on the Naranjo adverse event probability scale, the association between this serotonin syndrome and of fentaNYL and citalopram was considered probable.8

Levorphanol and Fentanyl: Common Questions

How serious is the Levorphanol and Fentanyl interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Levorphanol and Fentanyl interaction managed?

Your care team can manage this combination, but it needs careful oversight. They usually reserve the combination for when other options aren't adequate. If both are needed, doses are kept as low as works and used for as short a time as possible. Doses may need to be adjusted and individualized by your care team based on how you respond. Your team may monitor you more closely for sleepiness, slowed… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Levorphanol with Fentanyl?

The interaction record says a different medicine may be considered in place of one of these two.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Levorphanol and Fentanyl Interaction

Ask in your own words about taking Levorphanol and Fentanyl together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (8)

  1. Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Rising Pharma Holdings, Inc. (per FDA), East Brunswick, NJ, 2025. DailyMed
  2. Product Information: ACTIQ® oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2025. DailyMed
  3. Product Information: FENTORA® buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2025.
  4. Rastogi R, Swarm RA, & Patel TA: Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115(6):1291-1298. PubMed
  5. Alkhatib AA, Peterson KA, & Tuteja AK: Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 2010; 55(1):215-216. DOI
  6. Kirschner R & Donovan JW: Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 2010; 38(4):477-480. PubMed
  7. Rang ST, Field J, & Irving C: Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 2008; 55(8):521-525. DOI
  8. Ailawadhi S, Sung KW, Carlson LA, et al: Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007; 32(2):199-202. PubMed
Was this write-up helpful?

Other Serious Interactions of Levorphanol and Fentanyl

Also serious with Fentanyl

Also serious with Levorphanol

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Fentanyl

With Levorphanol

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.